Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |